Brief: Immunotech Biopharm Granted Breakthrough Therapy Designation

Immunotech Biopharm

05/09/2023 11:40

Sept 5 (Reuters) - Immunotech Biopharm Ltd  6978.HK :
    * GRANTED BREAKTHROUGH THERAPY DESIGNATION FOR PREVENTION OF
POSTSURGICAL RECURRENCE OF LIVER CANCER
    * BREAKTHROUGH THERAPY DESIGNATION BY CENTER FOR DRUG
EVALUATION
OF NATIONAL MEDICAL PRODUCTS ADMINISTRATION

Further company coverage:  6978.HK 

 ((Reuters.Briefs@thomsonreuters.com;))